Study of SGM-1019 in Patients With Nonalcoholic Steatohepatitis (NASH)

NCT03676231 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
9
Enrollment
INDUSTRY
Sponsor class

Stopped Study terminated due to a safety event which rendered the risk-benefit profile in NASH to no longer be adequately favorable

Conditions

Interventions

Sponsor

Second Genome